XML 88 R75.htm IDEA: XBRL DOCUMENT v3.19.1
Geographic and Segment Information (Segment Info) (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
geographic_region
segment
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
Segment Reporting Information [Line Items]      
Reportable segments | segment 2    
Number of geographic regions in which entity operates | geographic_region 3    
Net sales $ 250,801 $ 250,398  
Total reportable segment (loss) income from continuing operations (5,679) 26,172  
Merger and integration expenses 3,251 2,960  
Charges 2,533 1,881  
Amortization of intangibles 9,316 8,801  
Operating (loss) income from continuing operations (20,779) 12,530  
Interest income 249 447  
Interest expense (1,662) (2,111)  
Gain on acquisition 0 11,484  
Foreign exchange and other gains (losses) 729 (273)  
(Loss) income from continuing operations before tax (21,463) 22,077  
Assets 2,599,544   $ 2,549,701
Capital expenditures 4,883 5,846  
Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 250,801 250,398  
Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 155,491 156,172  
Charges 422 1,341  
Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 94,649 93,844  
Charges 432 6  
Other      
Segment Reporting Information [Line Items]      
Total reportable segment (loss) income from continuing operations (28,299) (22,820)  
Charges 1,679 534  
Assets 304,424   285,036
Capital expenditures 929 1,443  
Continuing Operations | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Total reportable segment (loss) income from continuing operations 989 10,258  
Assets 1,561,813   1,532,825
Capital expenditures 3,551 3,131  
Continuing Operations | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Total reportable segment (loss) income from continuing operations 21,631 38,734  
Assets 733,307   $ 731,840
Capital expenditures 403 347  
Discontinued Operations      
Segment Reporting Information [Line Items]      
Capital expenditures 0 925  
United States | Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 128,398 122,973  
United States | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 51,512 44,981  
United States | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 76,886 77,992  
Europe | Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 56,852 59,277  
Europe | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 46,193 48,986  
Europe | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 10,659 10,291  
Rest of world | Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 65,551 68,148  
Rest of world | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 57,786 62,205  
Rest of world | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 7,104 5,561  
Rest of world | Other      
Segment Reporting Information [Line Items]      
Net sales 661 382  
Cardiopulmonary | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 121,570 125,130  
Cardiopulmonary | United States | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 39,123 38,445  
Cardiopulmonary | Europe | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 35,561 36,870  
Cardiopulmonary | Rest of world | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 46,886 49,815  
Heart Valves | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 25,673 31,042  
Heart Valves | United States | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 4,356 6,536  
Heart Valves | Europe | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 10,513 12,116  
Heart Valves | Rest of world | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 10,804 12,390  
Advanced Circulatory Support | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 8,248 0  
Advanced Circulatory Support | United States | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 8,033 0  
Advanced Circulatory Support | Europe | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 119 0  
Advanced Circulatory Support | Rest of world | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales $ 96 $ 0